Salem Investment Counselors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.32M Sell
19,075
-4,400
-19% -$304K 0.04% 179
2025
Q1
$1.65M Buy
23,475
+1,549
+7% +$109K 0.06% 156
2024
Q4
$1.89M Buy
21,926
+491
+2% +$42.2K 0.06% 154
2024
Q3
$2.55M Buy
21,435
+1,637
+8% +$195K 0.08% 134
2024
Q2
$2.83M Buy
19,798
+6,338
+47% +$905K 0.09% 125
2024
Q1
$1.74M Buy
13,460
+11,318
+528% +$1.46M 0.06% 155
2023
Q4
$222K Hold
2,142
0.01% 338
2023
Q3
$195K Buy
2,142
+504
+31% +$45.8K 0.01% 340
2023
Q2
$133K Sell
1,638
-1,040
-39% -$84.2K ﹤0.01% 374
2023
Q1
$215K Hold
2,678
0.01% 325
2022
Q4
$181K Buy
2,678
+2,660
+14,778% +$180K 0.01% 344
2022
Q3
$1K Hold
18
﹤0.01% 1001
2022
Q2
$1K Hold
18
﹤0.01% 1032
2022
Q1
$1K Hold
18
﹤0.01% 970
2021
Q4
$1K Hold
18
﹤0.01% 1042
2021
Q3
$1K Hold
18
﹤0.01% 938
2021
Q2
$1K Hold
18
﹤0.01% 872
2021
Q1
$1K Hold
18
﹤0.01% 838
2020
Q4
$1K Buy
+18
New +$1K ﹤0.01% 772
2018
Q3
Sell
-2,600
Closed -$60K 500
2018
Q2
$60K Hold
2,600
0.01% 276
2018
Q1
$63K Hold
2,600
0.01% 264
2017
Q4
$70K Buy
2,600
+1,600
+160% +$43.1K 0.01% 278
2017
Q3
$24K Sell
1,000
-1,600
-62% -$38.4K ﹤0.01% 382
2017
Q2
$56K Sell
2,600
-5,450
-68% -$117K 0.01% 302
2017
Q1
$139K Sell
8,050
-86
-1% -$1.49K 0.01% 264
2016
Q4
$146K Sell
8,136
-12,564
-61% -$225K 0.02% 253
2016
Q3
$4.31K Sell
20,700
-3,200
-13% -$666 0.06% 171
2016
Q2
$643K Hold
23,900
0.08% 161
2016
Q1
$648K Hold
23,900
0.08% 154
2015
Q4
$694K Sell
23,900
-2,000
-8% -$58.1K 0.09% 153
2015
Q3
$696K Buy
25,900
+2,000
+8% +$53.7K 0.09% 153
2015
Q2
$654K Sell
23,900
-600
-2% -$16.4K 0.08% 165
2015
Q1
$654K Hold
24,500
0.08% 173
2014
Q4
$518K Hold
24,500
0.06% 189
2014
Q3
$583K Hold
24,500
0.07% 180
2014
Q2
$566K Buy
24,500
+4,000
+20% +$92.4K 0.07% 184
2014
Q1
$468K Buy
+20,500
New +$468K 0.06% 200